Asset Management One Co., Ltd. Incyte Corp Transaction History

Asset Management One Co., Ltd.

$27.7 Billion
Q3 2024

A detailed history of Asset Management One Co., Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 88,887 shares of INCY stock, worth $6.45 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

88,887

Previous 90,865 2.18%

Holding current value

$6.45 Million

Previous $5.51 Million 6.66%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$57.33 - $68.61 $113,398 - $135,710	-1,978 Reduced 2.18%	88,887 $5.88 Million
Q2 2024 Jul 18, 2024	SELL	$51.18 - $63.75 $644,305 - $802,548	-12,589 Reduced 12.17%	90,865 $5.51 Million
Q1 2024 May 02, 2024	SELL	$56.55 - $66.59 $345,916 - $407,331	-6,117 Reduced 5.58%	103,454 $5.89 Million
Q4 2023 Jan 24, 2024	BUY	$52.16 - $64.19 $461,668 - $568,145	8,851 Added 8.79%	109,571 $6.88 Million
Q3 2023 Oct 19, 2023	SELL	$57.77 - $65.93 $192,316 - $219,480	-3,329 Reduced 3.2%	100,720 $5.82 Million
Q2 2023 Jul 31, 2023	SELL	$60.95 - $75.51 $215,519 - $267,003	-3,536 Reduced 3.29%	104,049 $6.48 Million
Q1 2023 Apr 25, 2023	SELL	$70.23 - $86.01 $153,312 - $187,759	-2,183 Reduced 1.99%	107,585 $7.78 Million
Q4 2022 Feb 06, 2023	SELL	$67.18 - $84.11 $710,898 - $890,052	-10,582 Reduced 8.79%	109,768 $8.82 Million
Q3 2022 Nov 04, 2022	SELL	$66.18 - $82.86 $179,413 - $224,633	-2,711 Reduced 2.2%	120,350 $8.02 Million
Q2 2022 Jul 29, 2022	BUY	$66.18 - $83.18 $343,474 - $431,704	5,190 Added 4.4%	123,061 $9.35 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $972,870 - $1.17 Million	-14,736 Reduced 11.11%	117,871 $9.36 Million
Q4 2021 Feb 09, 2022	BUY	$63.34 - $74.11 $412,850 - $483,048	6,518 Added 5.17%	132,607 $9.78 Million
Q3 2021 Nov 02, 2021	SELL	$68.67 - $84.02 $321,512 - $393,381	-4,682 Reduced 3.58%	126,089 $8.67 Million
Q2 2021 Aug 03, 2021	BUY	$79.87 - $87.53 $1.88 Million - $2.06 Million	23,488 Added 21.89%	130,771 $11 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $1.11 Million - $1.47 Million	-14,633 Reduced 12.0%	107,283 $8.72 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $1.33 Million - $1.61 Million	16,489 Added 15.64%	121,916 $10.5 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $121,309 - $156,417	-1,426 Reduced 1.33%	105,427 $9.46 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $731,563 - $1.07 Million	-9,862 Reduced 8.45%	106,853 $11.1 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $47,511 - $64,649	752 Added 0.65%	116,715 $8.55 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $53,100 - $69,588	-727 Reduced 0.62%	115,963 $10.1 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $56,508 - $67,139	-776 Reduced 0.66%	116,690 $8.66 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $566,471 - $683,433	-7,705 Reduced 6.16%	117,466 $9.98 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $13.2 Million - $18.3 Million	-208,054 Reduced 62.44%	125,171 $10.8 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $142,506 - $170,373	2,436 Added 0.74%	333,225 $21.1 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $133,935 - $161,004	-2,169 Reduced 0.65%	330,789 $22.8 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $619,209 - $854,580	10,176 Added 3.15%	332,958 $22.2 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $635,492 - $772,597	-7,651 Reduced 2.32%	322,782 $26.9 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $1.82 Million - $2.27 Million	-19,493 Reduced 5.57%	330,433 $31.3 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.71 Million - $3.43 Million	24,805 Added 7.63%	349,926 $40.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	325,121	325,121 $41.2 Million

Others Institutions Holding INCY

# of Institutions

652

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Incyte Corp Transaction History